 |
 |
 |
|
PHARMACOKINETICS OF DOLUTEGRAVIR 100 MG ONCE-DAILY WITH RIFAMPICIN
|
|
|
Reported by jules Levin
19th International Workshop on Clinical Pharmacology of Antiviral Therapy 2018, 22-24 May 2018 Baltimore, USA
X WANG1, M CERRONE2, F FERRETTI2, N CASTRILLO2, G MAARTENS3, M MCCLURE1, M BOFFITO1,2*.
1. IMPERIAL COLLEGE LONDON 2. ST. STEPHEN'S CENTRE, CHELSEA AND WESTMINSTERHOSPITAL 3. UNIVERSITY OF CAPE TOWN







|
|
|
 |
 |
|
|